Mode of action of Withaferin A and Withanolide D.
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D002782:Cholestenes / Q000494:pharmacology*; D002783:Cholestenones / Q000494:pharmacology*; D003864:Depression, Chemical; D004988:Ethers, Cyclic / Q000494:pharmacology; D007783:Lactones / Q000494:pharmacology; D008297:Male; D051379:Mice; D009368:Neoplasm Transplantation; D010649:Phenylalanine / Q000378:metabolism; D012334:RNA, Neoplasm / Q000096:biosynthesis; D012510:Sarcoma 180 / Q000378:metabolism; D014184:Transplantation, Homologous; D014498:Uracil / Q000378:metabolism; D054358:Withanolides
D000970:Antineoplastic Agents; D002782:Cholestenes; D002783:Cholestenones; D004988:Ethers, Cyclic; D007783:Lactones; D012334:RNA, Neoplasm; D054358:Withanolides; C010376:withanolide D; D010649:Phenylalanine; D014498:Uracil; C009684:withaferin A